PDCD1 and gastric cancer: The multivariate analyses indicated that PD-L1 CPS (P < 0.05) and percentage of PD-1+ lymphocytes in TEM (P < 0.01) were independent prognostic factors for survival times in advanced GC patients receiving chemoimmunotherapy.